What segments are covered in this report?

The South & Central America Neurorehabilitation Devices Market report typically cover these key segments- 产品类型（神经机器人系统、脑机接口、非侵入性刺激器、可穿戴设备）应用（中风、脑外伤、脊髓损伤、帕金森病、脑瘫）最终用户（康复中心、医院和诊所、家庭护理）

What is the historic period, base year, and forecast period taken for South & Central America Neurorehabilitation Devices Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Neurorehabilitation Devices Market report: 2025-2031 2023 2021-2023

Who are the major players in South & Central America Neurorehabilitation Devices Market?

The South & Central America Neurorehabilitation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Abbott Laboratories ; BIONIK ; BioXtreme Ltd ; Blackrock Microsystems Inc ; Ekso Bionics Holdings Inc ; EMOTIV ; Hocoma AG ; Medtronic Plc ; Renishaw Plc ; Tyromotion GmbH

Who should buy this report?

The South & Central America Neurorehabilitation Devices Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the South & Central America Neurorehabilitation Devices Market value chain can benefit from the information contained in a comprehensive market report.

南美和中美神经康复设备市场（主要地区、市场参与者、规模和份额）- 预测至 2031 年

2023 年，南美和中美神经康复设备市场价值为 1.0424 亿美元，预计到 2031 年将达到 2.2117 亿美元；预计 2023 年至 2031 年的复合年增长率为 9.9%。

市场参与者的战略举措推动南美和中美神经康复设备市场发展

市场参与者采取的合并、收购、建立合作伙伴关系和协作等战略举措可能会加速创新、发展专业知识并扩大市场范围。

2022 年 4 月，Blackrock Neurotech 与神经科技初创公司 Phantom Neuro 合作，对 Phantom Neuro 正在申请专利的 Phantom X 系统进行研发，该系统为患者提供对当前和下一代辅助设备（如假肢和外骨骼）的高度精确、几乎实时的控制。通过此次研发合作，Phantom 能够利用 Blackrock 在神经技术领域数十年的经验，开发生物相容性植入式传感器，以补充和支持 Phantom X 平台。

2022 年 12 月，医疗外骨骼技术领导者 Ekso Bionics 宣布收购派克汉尼汾公司的人体运动与控制（“HMC”）业务部门。此次收购将增强 Ekso 的产品组合，并改善其与范德比尔特大学等商业和研究伙伴的战略关系。与范德比尔特的合作有望增强其研究能力和产品开发。

因此，市场参与者采取的战略举措很可能在不久的将来为神经康复市场创造丰厚的商机。

南美和中美神经康复设备市场概览

南美和中美神经康复设备市场分为巴西、阿根廷和南美和中美其他地区，巴西占有最大的市场份额。一些神经系统疾病的流行与巴西人口老龄化有关。根据泛美卫生组织 2022 年的数据，巴西 60 岁及以上老年人口超过 3000 万，占全国人口的 13%。到 2030 年，这个年龄段的人数将达到近 5000 万，占巴西总人口的 24%。世界卫生组织 (WHO) 和巴西地理统计局报告称，到 2040 年，巴西老年人口（60 岁及以上）预计将达到约 5500 万。因此，帕金森病等神经系统疾病发病率的上升可能会在未来几年推动神经康复的需求。巴西的许多机构都在致力于巴西神经科学的发展。

南美和中美神经康复设备市场收入及预测至2031年（百万美元）

南美和中美神经康复设备市场细分

南美和中美神经康复设备市场按产品类型、应用、最终用户和国家/地区分类。

按产品类型，南美和中美神经康复设备市场细分为神经机器人系统、脑机接口、非侵入性刺激器和可穿戴设备。脑机接口细分市场在2023年占据南美和中美神经康复设备市场的最大份额。

按应用分类，南美和中美神经康复设备市场细分为中风、创伤性脑损伤、脊髓损伤、帕金森病、脑瘫等。 2023 年，中风部分占据南美和中美洲神经康复设备市场的最大份额。

按最终用户划分，南美和中美洲神经康复设备市场分为康复中心、医院和诊所以及家庭护理。2023 年，医院和诊所部分占据南美和中美洲神经康复设备市场的最大份额。

根据国家/地区，南美和中美洲神经康复设备市场分为巴西、阿根廷和南美和中美洲其他地区。2023 年，巴西部分占据南美和中美洲神经康复设备市场的最大份额。

雅培实验室；BIONIK；BioXtreme Ltd；贝莱德微系统公司；Ekso Bionics Holdings Inc；EMOTIV；Hocoma AG；美敦力公司；雷尼绍公司；和 Tyromotion GmbH 是南美和中美神经康复设备市场的一些领先公司。

South & Central America Neurorehabilitation Devices Strategic Insights

Strategic insights for South & Central America Neurorehabilitation Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-neurorehabilitation-devices-market-strategic-framework.webp

Get more information on this report

South & Central America Neurorehabilitation Devices Report Scope

Report Attribute	Details
Market size in 2023	US$ 104.24 Million
Market Size by 2031	US$ 221.17 Million
Global CAGR (2023 - 2031)	9.9%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 产品类型（神经机器人系统、脑机接口、非侵入性刺激器、可穿戴设备） By 应用（中风、脑外伤、脊髓损伤、帕金森病、脑瘫） By 最终用户（康复中心、医院和诊所、家庭护理）
Regions and Countries Covered	南美洲和中美洲（巴西、阿根廷、南美洲和中美洲其他地区）南美洲和中美洲（巴西、阿根廷、南美洲和中美洲其他地区）
Market leaders and key company profiles	Abbott Laboratories BIONIK BioXtreme Ltd Blackrock Microsystems Inc Ekso Bionics Holdings Inc EMOTIV Hocoma AG Medtronic Plc Renishaw Plc Tyromotion GmbH

Get more information on this report

South & Central America Neurorehabilitation Devices Regional Insights

The regional scope of South & Central America Neurorehabilitation Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.